As of Aug 31
| +0.12 / +2.55%|
The 3 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 11.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +128.22% increase from the last price of 4.82.
The current consensus among 3 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.